Diabetic Medicine · 2008 · 26 citations · 6 references
To the best of our knowledge, this is the first case to document spontaneous resolution of CSMO and improvement in VA on discontinuation of a glitazone. Glitazones have a definitive role in the management of diabetic patients and ophthalmologists and physicians should both be aware that there may be an association with weight gain, peripheral oedema and CSMO. We recommend that ophthalmologists consider discontinuing glitazones in consultation with the diabetologist before embarking on interventional management such as laser or intravitreal injections.
6
George H. Bresnick · Ophthalmology · 1986 · 415 citations
Glitazones: clinical effects and molecular mechanisms
Michael Stümvoll, Hans‐Ulrich Häring · Annals of Medicine · 2002 · 222 citations · Full text
DIABETIC MACULAR EDEMA ASSOCIATED WITH GLITAZONE USE
Edwin H. Ryan, Dennis P. Han, Robert C. Ramsay et al. · Retina · 2006 · 135 citations
Effects of haemodialysis on diabetic macular leakage
T. Tokuyama · British Journal of Ophthalmology · 2000 · 69 citations · Full text